tirzepatide oral tablets vs injection Oral Tirzepatide: Availability, Alternatives, and

In March, Eli Lilly launched Mounjaro (tirzepatide) and Novo Nordisk followed with Wegovy (semaglutide) in June

Research published in the New England Journal of Medicine demonstrated that patients taking tirzepatide had significant reductions in A1c levels over 40 weeks (Jastreboff et al., 2022)

User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses

Hair loss again did not appear on that list

Fresh injection needles for each injection are non-negotiable